Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid peroxidation by bleomycin-iron complexes in vitro.

H Ekimoto, K Takahashi, A Matsuda

    The Journal of Antibiotics
    |August 1, 1985
    PubMed
    Summary

    Bleomycin-iron complexes induce lipid peroxidation. Antioxidants inhibit this process, but the specific reactive species differ between bleomycin-iron(II) and bleomycin-iron(III) complexes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    BCS-like Bogoliubov quasiparticles in high-T(c) superconductors observed by angle-resolved photoemission spectroscopy.

    Physical review letters·2003
    Same author

    Low energy excitation and scaling in Bi(2)Sr(2)Ca(n-1)Cu(n)O(2n+4) (n=1-3): angle-resolved photoemission spectroscopy.

    Physical review letters·2002
    Same author

    Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.

    Annals of hematology·2002
    Same author

    [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2002
    Same author

    The molecular basis for the alternative stable phenotype in a behavioral mutant of Paramecium tetraurelia.

    Genes & genetic systems·2002
    Same author

    Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2001

    Area of Science:

    • Biochemistry
    • Oxidative Stress Research

    Background:

    • Bleomycin (BLM) is an anticancer drug known to form complexes with metal ions.
    • Metal-bleomycin complexes can generate reactive oxygen species, potentially leading to cellular damage.
    • Lipid peroxidation is a key indicator of oxidative damage to cell membranes.

    Purpose of the Study:

    • To investigate the role of bleomycin-metal complexes in catalyzing lipid peroxidation.
    • To differentiate the mechanisms of lipid peroxidation induced by different bleomycin-metal complexes, particularly iron complexes.
    • To identify the reactive species involved in bleomycin-induced lipid peroxidation.

    Main Methods:

    • In vitro study using arachidonic acid as a substrate for lipid peroxidation.
    • Incubation of bleomycin with various metal ions, focusing on iron (Fe(II) and Fe(III)).
    • Assessment of inhibition by antioxidants (dl-alpha-tocopherol, ascorbic acid) and radical scavengers.

    Main Results:

    • Iron complexes of bleomycin (BLM-Fe) extensively catalyzed lipid peroxidation of arachidonic acid.
    • Other metal-BLM complexes did not show significant lipid peroxidation activity.
    • Antioxidants inhibited BLM-Fe-induced lipid peroxidation, while other radical scavengers did not.
    • Cyanide suppressed BLM-Fe(II)-induced peroxidation but not BLM-Fe(III)-induced peroxidation.
    • BLM-Fe(II) activity was lost upon pre-incubation, unlike BLM-Fe(III).

    Conclusions:

    • Bleomycin-iron complexes are potent catalysts of lipid peroxidation.
    • The active species responsible for lipid peroxidation differ between bleomycin-iron(II) and bleomycin-iron(III) complexes.
    • These findings suggest distinct mechanisms of oxidative damage mediated by different iron oxidation states in bleomycin complexes.

    Related Experiment Videos